Managing the Anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin*
References (53)
Anemia of prematurity. Current concepts in the issue of when to transfuse
Pediatr Clin North Am
(1986)- et al.
Postnatal changes in erythropoietin levels in untransfused premature infants
J Pediatr
(1983) - et al.
Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity
J Pediatr
(1984) - et al.
Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with “anemia of prematurity”
J Pediatr
(1988) - et al.
Postnatal changes in serum Ep in relation to hypoxia before and after birth
J Pediatr
(1990) - et al.
Effect of booster blood transfusions on oxygen utilization in infants with bronchopulmonary dysplasia
J Pediatr
(1988) Neonatal apnea: Pathogenesis and therapy
J Pediatr
(1977)- et al.
Feasibility and safety of AS-3 red blood cells for neonatal transfusions
J Pediatr
(2000) - et al.
Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates
J Pediatr
(1994) - et al.
Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells
J Pediatr
(1995)
Exchange transfusion in the newborn infant with fresh and “old” blood: The role of storage on a 2,3-diphosphoglycerate, hemoglobin-oxygen affinity and oxygen release
J Pediatr
(1971)
Comparison of two preservation solutions for erythrocyte transfusions in newborn infants
J Pediatr
(1993)
Nutricel as an additive solution for neonatal transfusion
Transfus Sci
(1999)
Recombinant erythropoietin in the treatment of the premature newborn
Semin Neonatal
(1998)
The role of erythropoietin in the anemia of prematurity
Sem Perinatol
(1997)
Changing patterns of red blood cell transfusions in very low birth weight infants
J Pediatr
(1996)
Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g
J Pediatr
(2000)
Effect of high doses of human recombinant erythroprotein on the need for blood transfusions in preterm infants
J Pediatr
(1992)
Tissue distribution of erythropoictin and erythropoietin receptor in the developing human fetus
Early Human Development
(1998)
Current issues in neonatal transfusions
Vox Sang
(1986)
Erythropoietin in the pathogenesis and treatment of neonatal anemia
Transfusion
(1995)
Circulating erythroid progenitors in the anemia of prematurity
N Eng J Med
(1987)
Erythroid colonies derived from fetal blood display different growth patterns from those derived from adult marrow
Pediatr Res
(1988)
Studies in the liver to kidney switch of erythropoietin production
J Clin Invest
(1981)
Erythropoietin mRNA expression in human fetal and neonatal tissue
Blood
(1998)
Erythropoietin pharmacokinetics in premature infants: Developmental, nonlinearity, and treatment effects
J App Physiol
(1996)
Cited by (25)
One Pathway to Academic Success: Autobiography of Dr Ronald G. Strauss
2012, Transfusion Medicine ReviewsAnaemia of prematurity: Pathophysiology and treatment
2010, Blood ReviewsCitation Excerpt :On one hand, clonogenic erythroid progenitors from neonates respond well to r-HuEPO in vitro and r-HuEPO and iron effectively stimulate erythropoiesis in vivo as evidenced by increased blood reticulocyte and RBC counts in recipient infants (i.e., efficacy successful at the marrow level). On the other hand, when the primary goal of r-HuEPO therapy is to eliminate RBC transfusions, r-HuEPO often fails to do so (i.e., efficacy at the clinical level has not been consistently successful).20,35 By the end of 1999, over 20 controlled clinical trials assessing the efficacy of r-HuEPO to eliminate RBC transfusions in the anaemia of prematurity were published with inconsistent results.
Recombinant erythropoietin for the treatment of anemia of prematurity: Is it beneficial?
2004, Newborn and Infant Nursing ReviewsAnemia of prematurity
2004, Journal de Pediatrie et de PuericultureErythropoietin administration to preterm infants: Comparison between subcutaneous and intravenous route
2004, Archives de Pediatrie
- *
Supported by NIH grants PO1 HL46925 and RR00059.
Copyright © 2001 Published by Elsevier Inc.